What is the best investment? If you could go back nine months, bit B would be the best choice. Bitcoin, which costs less than $20,000 each, has been on a tear since November, breaking the $60,000 mark in April. In just half a year, the rise of more than three times, a new wealth myth seems to have emerged. However, the ensuing plunge quickly exposed the fragility of this new myth.
At the same time, the elders who have stirred this storm of wealth appear to be actively looking for another home. After Ether founder Vitalik, one of the founders of the coin community, poured $2.4 million into the SENS Foundation, which focuses on biotechnology research, Richard, founder of cryptocurrency HEX, also extended an olive branch, indirectly injecting more than $25 million in four days.
The big boys get together again in biotech
According to the Daily Express, Richard recently declared that donors who support SENS will receive PulseChain, a digital currency in proportion to the amount they give. An outpouring of supporters donated $25 million to SENS in just five days.
SENS was founded by Dr. Aubrey, a renowned British health specialist, to develop solutions to the problems associated with aging. In other words, the SENS did exactly what the Qin and Han dynasties sought to do, but in a more scientific way. The currency circle has been associated with this field for a long time. Last year Vitalik publicly declared that aging is a disaster no less than the Second World War, and that “all investments are better than anti-aging investments.” He later put $2.4 million into SENS.
In fact, it is not just the bigwigs who want to share a piece of the pie in this field. Unity, backed by The richest man in the United States and PAYPAL co-founder Peter Thiel, has successfully gone public in the United States. Lee, a Hong Kong tycoon over 90, is more eager to do so. He supports research on gene editing and Unity, and has invested 25 million US dollars in ChromaDex……, a company related to Pavirox
As the intervention ages, it could generate trillions of dollars in economic benefits
Intertwined capital has tested the water to fight the old field, the prospects of the field what? In 2019, the famous investment bank Bank of America Merrill Lynch once made a research analysis, they believe that this field is one of the biggest investment opportunities in the next decade, the market size is expected to reach 600 billion dollars by 2025. Earlier this July, Andrew Scott and his team at London Business School reported in Nature Aging that economic models estimate that the economic benefits of aging could amount to trillions of dollars.
Research from London Business School shows that as living standards have risen, there has been a significant general increase in people’s willingness to spend to fight old age. Unfortunately, rich people like Richard and Bezos are in love with long-term cutting-edge technology, whether it is gene editing, Unity or SENS research is still in the laboratory stage, only the “Paviro-like” li bet on actually hit the ground and create practical benefits, but it is a pity that others have been there first.
According to published data, harvard Medical School, the University of Washington, Tokyo Medical School and others have conducted experiments on the substance, which stabilizes DNA, prolongs telomeres and extends the life span of animals. Recently, the University of Tokyo organized a group of people over 55 to take the substance daily. After 12 weeks, the elderly showed significant improvement in hearing, bone density, muscle strength and other indicators.
Japanese firms, the true (Bioagen) through the right place and the related institutions to achieve cooperation, the distribution of the material, the ground results “send D collaterals” more popular than lee’s investment of the initial results, is known as “youth”, successively into the ise Dan), and super large pill department such as local domestic part also D by Beijing international access to the rich. Judging by the feedback in the comments section, it seems to be working.
Heading for the heights of life at 150?
Earlier this year, Aubrey, invited to an industry forum hosted by fudan University’s time School, a leading anti-aging science team, boldly predicted that biotechnology is exploding exponentially and that by 2036, we will see a double leap in the length and quality of life. A recent singapore-US paper published in Nature Communication goes some way to confirming this. After analysing the medical indicators of 544,398 volunteers, they conclude that we can expect to live to 150 this century.
The technology seems to have lived up to expectations. In June, Israeli scientists announced that they had identified SIRT6, a key gene that affects the length of life in mice. Jennifer’s company, which won a Nobel Prize for gene editing, announced positive results in phase I clinical trials. Currently, LABS around the world are actively screening various targeted genes, while other cutting-edge technologies are being advanced.
We may indeed be able to reach 150 in 2036, but we just don’t know who will get the biggest share of this huge change.